PRAC2
gene geneOn this page
Summary
PRAC2 (PRAC2 small nuclear protein, HGNC:30143) is a protein-coding gene on chromosome 17q21.32, encoding Protein PRAC2 (D3DTV9).
This gene is highly expressed in prostate, rectum, colon, and testis. This gene may produce a non-coding RNA or may encode a short protein that might localize to the nucleus. Alternative splicing results in multiple transcript variants.
Source: NCBI Gene 360205 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 1 total
- MANE Select transcript:
NM_001282275
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30143 |
| Approved symbol | PRAC2 |
| Name | PRAC2 small nuclear protein |
| Location | 17q21.32 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000229637 |
| Ensembl biotype | protein_coding |
| OMIM | 610787 |
| Entrez | 360205 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 11 protein_coding
ENST00000422730, ENST00000432056, ENST00000936781, ENST00000936782, ENST00000936783, ENST00000936784, ENST00000936785, ENST00000936786, ENST00000936787, ENST00000936788, ENST00000936789
RefSeq mRNA: 2 — MANE Select: NM_001282275
NM_001282275, NM_001282276
CCDS: CCDS74099, CCDS74100
Canonical transcript exons
ENST00000422730 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001602878 | 48724328 | 48724758 |
| ENSE00001605618 | 48723185 | 48723313 |
Expression profiles
Bgee: expression breadth broad, 32 present calls, max score 92.07.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1726 / max 33.0066, expressed in 52 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 161456 | 0.1081 | 37 |
| 161455 | 0.0644 | 28 |
Top tissues by expression
116 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 92.07 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.92 | silver quality |
| rectum | UBERON:0001052 | 82.02 | gold quality |
| prostate gland | UBERON:0002367 | 79.45 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 71.63 | gold quality |
| vagina | UBERON:0000996 | 58.89 | gold quality |
| right testis | UBERON:0004534 | 58.63 | gold quality |
| left testis | UBERON:0004533 | 57.77 | gold quality |
| placenta | UBERON:0001987 | 57.47 | gold quality |
| colonic epithelium | UBERON:0000397 | 57.36 | silver quality |
| testis | UBERON:0000473 | 56.77 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 53.89 | gold quality |
| urinary bladder | UBERON:0001255 | 53.74 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 52.53 | gold quality |
| colon | UBERON:0001155 | 49.97 | gold quality |
| transverse colon | UBERON:0001157 | 49.56 | gold quality |
| skin of leg | UBERON:0001511 | 45.19 | gold quality |
| intestine | UBERON:0000160 | 42.32 | gold quality |
| adipose tissue | UBERON:0001013 | 38.61 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ectocervix | UBERON:0012249 | 35.87 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 35.01 | gold quality |
| zone of skin | UBERON:0000014 | 34.80 | gold quality |
| uterine cervix | UBERON:0000002 | 34.54 | gold quality |
| cortex of kidney | UBERON:0001225 | 32.89 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-125970 | yes | 19.80 |
| E-ANND-3 | no | 2.62 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- PRAC2 may have a function in prostate growth and development(PRAC2) (PMID:12746837)
- our study indicated that HOXB13-AS1 could regulate HOXB13 gene expression by methylation HOXB13 promoter and acts as an epigenetic oncogenic in glioma. (PMID:30105866)
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Protein PRAC2 — D3DTV9 (reviewed: D3DTV9)
Alternative names: Prostate, rectum and colon expressed gene protein 2
All UniProt accessions (2): A0A087X2F6, D3DTV9
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Nucleus.
Tissue specificity. Highly expressed in prostate and testis. Also detected in placenta, muscle, colon, peripheral blood leukocytes and skin.
RefSeq proteins (2): NP_001269204, NP_001269205 (=MANE)
Domains & families (InterPro)
UniProt features (1 total): chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-D3DTV9-F1 | 60.27 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 7 (showing top):
ZNF407_TARGET_GENES, MED25_TARGET_GENES, GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_DN, GSE21927_SPLEEN_VS_BONE_MARROW_MONOCYTE_BALBC_DN, GSE25502_WT_VS_KLF13_KO_THYMIC_MEMORY_LIKE_CD8_TCELL_DN, chr17q21, GSE41867_NAIVE_VS_DAY15_LCMV_CONE13_EFFECTOR_CD8_TCELL_UP
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (2): nucleus (GO:0005634), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular membrane-bounded organelle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
76 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PRAC2 | PRAC1 | Q96KF2 | 985 |
| PRAC2 | HOXB13 | Q92826 | 916 |
| PRAC2 | TDRD10 | Q5VZ19 | 594 |
| PRAC2 | TMEM132C | Q8N3T6 | 526 |
| PRAC2 | ANKRD53 | Q8N9V6 | 419 |
| PRAC2 | CLXN | Q9HAE3 | 322 |
| PRAC2 | ZNF177 | Q13360 | 300 |
| PRAC2 | GXYLT2 | A0PJZ3 | 269 |
| PRAC2 | IL22RA1 | Q8N6P7 | 247 |
| PRAC2 | RIMBP2 | O15034 | 246 |
| PRAC2 | HOXD9 | P28356 | 239 |
| PRAC2 | RNF220 | Q5VTB9 | 231 |
| PRAC2 | ZNF154 | Q13106 | 225 |
| PRAC2 | C17orf107 | Q6ZR85 | 222 |
| PRAC2 | HOXB6 | P09068 | 222 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A087WWA1, A0A182BSS5, B1AUF7, D3DTV9, K8DWB5, O12987, O12995, O13557, O30006, O83592, P01073, P03124, P03846, P05679, P08771, P0C5P1, P0C841, P0CV22, P10437, P14311, P16773, P18455, P20218, P23183, P34245, P36283, P38303, P39978, P40519, P53194, P75320, P75602, P81056, P89888, Q04413, Q0UI01, Q28UQ5, Q31CC8, Q3BSH4, Q3E789
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
131 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:48723769:G:GT | donor_gain | 0.9900 |
| 17:48723819:GCC:G | donor_gain | 0.9800 |
| 17:48724323:CACA:C | acceptor_loss | 0.9400 |
| 17:48723927:G:GT | donor_gain | 0.9200 |
| 17:48724512:G:A | acceptor_gain | 0.8900 |
| 17:48724324:A:AG | acceptor_gain | 0.8800 |
| 17:48724325:C:G | acceptor_gain | 0.8700 |
| 17:48724326:A:AG | acceptor_gain | 0.8600 |
| 17:48724327:G:GG | acceptor_gain | 0.8600 |
| 17:48724107:GAATG:G | donor_gain | 0.8500 |
| 17:48724108:AATGG:A | donor_loss | 0.8200 |
| 17:48724109:ATGGT:A | donor_loss | 0.8200 |
| 17:48724110:TGGT:T | donor_loss | 0.8200 |
| 17:48724111:GGT:G | donor_loss | 0.8200 |
| 17:48724113:T:A | donor_loss | 0.8200 |
| 17:48724112:G:GG | donor_gain | 0.8100 |
| 17:48724114:AA:A | donor_loss | 0.8100 |
| 17:48724324:ACAG:A | acceptor_gain | 0.8100 |
| 17:48723943:G:GT | donor_gain | 0.8000 |
| 17:48724476:G:T | acceptor_gain | 0.7800 |
| 17:48723767:CGGAG:C | donor_loss | 0.7700 |
| 17:48723768:GGAGG:G | donor_loss | 0.7700 |
| 17:48723769:GAGG:G | donor_loss | 0.7700 |
| 17:48723770:AGGTA:A | donor_loss | 0.7700 |
| 17:48723771:G:C | donor_loss | 0.7700 |
| 17:48723772:G:GG | donor_loss | 0.7700 |
| 17:48723773:T:C | donor_loss | 0.7700 |
| 17:48723816:G:GT | donor_gain | 0.7700 |
| 17:48723892:A:AG | donor_gain | 0.7600 |
| 17:48723944:G:T | donor_gain | 0.7500 |
AlphaMissense
573 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:48724678:T:A | W90R | 0.900 |
| 17:48724678:T:C | W90R | 0.900 |
| 17:48724504:T:C | F32L | 0.895 |
| 17:48724506:C:A | F32L | 0.895 |
| 17:48724506:C:G | F32L | 0.895 |
| 17:48724680:G:C | W90C | 0.847 |
| 17:48724680:G:T | W90C | 0.847 |
| 17:48724554:G:C | W48C | 0.767 |
| 17:48724554:G:T | W48C | 0.767 |
| 17:48724499:T:A | L30H | 0.746 |
| 17:48724462:T:C | F18L | 0.740 |
| 17:48724464:C:A | F18L | 0.740 |
| 17:48724464:C:G | F18L | 0.740 |
| 17:48724679:G:T | W90L | 0.733 |
| 17:48724552:T:A | W48R | 0.721 |
| 17:48724552:T:C | W48R | 0.721 |
| 17:48724679:G:C | W90S | 0.721 |
| 17:48724494:C:A | N28K | 0.720 |
| 17:48724494:C:G | N28K | 0.720 |
| 17:48724502:C:A | A31D | 0.695 |
| 17:48724496:T:C | L29P | 0.690 |
| 17:48724517:T:A | L36H | 0.686 |
| 17:48724535:T:A | I42K | 0.682 |
| 17:48724496:T:A | L29H | 0.679 |
| 17:48724513:G:C | G35R | 0.676 |
| 17:48724535:T:C | I42T | 0.673 |
| 17:48724507:T:C | F33L | 0.654 |
| 17:48724509:C:A | F33L | 0.654 |
| 17:48724509:C:G | F33L | 0.654 |
| 17:48724505:T:C | F32S | 0.650 |
dbSNP variants (sampled 300 via entrez): RS1000231825 (17:48724469 T>C), RS1000662927 (17:48720065 G>T), RS1000832817 (17:48724735 G>A,C), RS1000965281 (17:48720261 G>A), RS1002156604 (17:48721412 A>G), RS1002619350 (17:48724025 A>T), RS1002688631 (17:48719477 G>A,C), RS1002880445 (17:48719980 C>G,T), RS1003273521 (17:48724421 G>A,C), RS1003537481 (17:48719241 A>ACACACACACACG,ACACACACACG,ACACACACG,ACACACG), RS1003545094 (17:48717350 T>A), RS1003661167 (17:48718624 C>A,T), RS1004376713 (17:48717044 A>G), RS1004405529 (17:48719650 T>C), RS1004681436 (17:48725112 G>A,T)
Disease associations
OMIM: gene MIM:610787 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| entinostat | increases expression | 1 |
| Arsenic | increases methylation | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Drugs, Chinese Herbal | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.